SARS CoV 2 Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Completed
  • SARS-CoV 2
  • Hyperimmune plasma
  • Standard of care for SARS-CoV-2 infection
  • Jerez de la Frontera, Cádiz, Spain
  • +13 more
2022-04-05
Apr 5, 2022
M
Completed
  • SARS-CoV 2
  • Intramuscular Vaccine
  • Montréal, Quebec, Canada
  • +1 more
2022-04-04
Apr 4, 2022
I
Recruiting
  • COVID
  • +4 more
    • Antwerp, Belgium
      Universitairy hospital of Antwerp
    2022-04-04
    Apr 4, 2022
    U
    Active, not recruiting
    • COVID-19
    • +4 more
    • BCG
    • Placebo
    • Campinas, SP, Brazil
      Hospital das Clínicas Unicamp
    2022-03-23
    Mar 23, 2022
    U
    Completed
    • Corona Virus Infection
    • +3 more
    • High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma
    • Charlottesville, Virginia
    • +1 more
    2022-03-30
    Mar 30, 2022
    E
    Recruiting
    • COVID-19
    • +2 more
      • Ipswich, United Kingdom
        East Suffolk and North Essex NHS Foundation Trust
      2022-03-21
      Mar 21, 2022
      U
      Active, not recruiting
      • COVID
      • +3 more
      • Data Collection
      • Denver, Colorado
      • +3 more
      2022-03-25
      Mar 25, 2022
      U
      Active, not recruiting
      • SARS-CoV 2
      • Blood sampling
      • Grenoble, France
        UniversityGrenobleHospital
      2022-03-24
      Mar 24, 2022
      R
      Completed
      • SARS-CoV 2
      • Los Angeles, California
      • +10 more
      2022-03-17
      Mar 17, 2022
      U
      Completed
      • Covid-19
      • +4 more
      • Use of virus (Covid-19) genome sequence report to inform infection prevention control procedures
      • London, United Kingdom
        University College London Hospitals NHS Foundation Trust
      2022-02-16
      Feb 16, 2022
      A
      Recruiting
      • SARS-CoV 2
      • +5 more
      • CAG length <22
      • CAG length >=22
      • Madrid, Spain
        Hospital Universitario Ramon y Cajal
      2022-02-17
      Feb 17, 2022
      U
      Active, not recruiting
      • COVID-19
      • SARS-CoV 2
      • 10% Povidone-iodine nasal decolonization swab plus 0.12% CHG oral rinse
      • Madison, Wisconsin
        University of Wisconsin-Madison
      2022-02-16
      Feb 16, 2022
      R
      Completed
      • SARS-CoV 2
      • COVID-19
      • 5-ALA-Phosphate + SFC (5-ALA + SFC)
      • Manama, Bahrain
      • +1 more
      2022-02-08
      Feb 8, 2022
      I
      Enrolling by invitation
      • Post Covid-19 Respiratory
      • +2 more
      • Respiratory Music Therapy Protocol
      • New York, New York
        Louis Armstrong Dept. of Music & Medicine, Mount Sinai Beth Isra
      2022-02-07
      Feb 7, 2022
      H
      Terminated
      • COVID-19
      • +3 more
      • Hydroxychloroquine - Daily Dosing
      • +6 more
      • Detroit, Michigan
      • +3 more
      2022-02-07
      Feb 7, 2022
      B
      Withdrawn
      • SARS-CoV 2
      • Phase 1
      • Phase 2
      • Boston, Massachusetts
        Brigham and Women's Hospital
      2022-01-21
      Jan 21, 2022
      U
      Active, not recruiting
      • SARS-CoV 2
      • +4 more
        • Dallas, Texas
          University of Texas Southwestern Medical Center
        2022-02-01
        Feb 1, 2022
        B
        Terminated
        • SARS-CoV 2
        • +2 more
        • Dose Finding Phase (MTD)
        • +2 more
        • Houston, Texas
          Houston Methodist Hospital
        2022-01-04
        Jan 4, 2022
        E
        Recruiting
        • SARS-CoV 2
        • Hospitalisation-Associated Infection
          • Stains, France
          • +1 more
          2022-01-03
          Jan 3, 2022
          U
          Recruiting
          • SARS-CoV 2
          • COVID-19
          • COVID-19 Antibody testing
          • Zurich, Switzerland
            Epidemiology, Biostatistics and Prevention Institute (EBPI), Uni
          2021-12-09
          Dec 9, 2021
          N
          Not yet recruiting
          • SARS-CoV 2
          • +5 more
          • ZYESAMI™ (aviptadil acetate)
          • +2 more
          • (no location specified)
          2021-12-06
          Dec 6, 2021
          S
          Terminated
          • COVID-19
          • SARS-CoV 2
          • Sioux Falls, South Dakota
            Sanford Health
          2021-12-08
          Dec 8, 2021
          K
          Completed
          • SARS-CoV 2
          • Throat swab sample for measuring current infection with SARS-CoV-2
          • Blood sample for serology to measure past infection with SARS-CoV-2
          • Stockholm, Sweden
            Karolinska University Hospital
          2021-12-02
          Dec 2, 2021
          S
          Recruiting
          • COVID-19
          • SARS-CoV 2
          • Carrageenan nasal and throat spray
          • Saline nasal and throat spray
          • Swansea, United Kingdom
            Joint Clinical Research Facility
          2021-12-01
          Dec 1, 2021